Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 80.31%18.96B | 32.48%10.52B | 90.26%4.63B | 14.02%2.05B | 1.86B | 1.98B | 7.94B | 2.43B | 1.8B |
| Cost of revenue | 134.65%2.79B | 173.96%1.19B | 339.53%756M | 110.00%189M | 123M | 120M | 434M | 172M | 90M |
| Gross profit | 73.39%16.17B | 24.30%9.33B | 71.30%3.87B | 8.96%1.86B | 1.73B | 1.86B | 7.5B | 2.26B | 1.71B |
| Operating expense | 75.63%15.96B | 24.51%9.09B | 70.28%3.59B | 14.60%1.92B | 1.76B | 1.81B | 7.3B | 2.11B | 1.68B |
| Selling and administrative expenses | 74.15%15.99B | 24.52%9.18B | 64.40%3.57B | 14.65%1.93B | --1.77B | --1.91B | --7.37B | --2.17B | --1.68B |
| -General and administrative expense | 74.15%15.99B | 24.52%9.18B | 64.40%3.57B | 14.65%1.93B | --1.77B | --1.91B | --7.37B | --2.17B | --1.68B |
| Other operating expenses | -94.00%3M | 117.39%50M | 117.65%37M | 66.67%5M | --1M | --6M | --23M | --17M | --3M |
| Total other operating income | -77.78%32M | 46.94%144M | -70.59%25M | 75.00%7M | --5M | --106M | --98M | --85M | --4M |
| Operating profit | -12.24%208M | 16.75%237M | 85.16%287M | -317.24%-63M | -32M | 45M | 203M | 155M | 29M |
| Net non-operating interest income (expenses) | -92.86%-108M | -24.44%-56M | -130.00%-23M | -18.18%-13M | -9M | -10M | -45M | -10M | -11M |
| Non-operating interest income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Non-operating interest expense | 92.86%108M | 24.44%56M | 130.00%23M | 18.18%13M | --9M | --10M | --45M | --10M | --11M |
| Net investment income | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||||||
| Income from associates and other participating interests | 0 | -2M | -2M | 0 | 0 | 0 | 0 | 0 | 0 |
| Special income (charges) | |||||||||
| Other non-operating income (expenses) | |||||||||
| Income before tax | -43.58%101M | 14.74%179M | 81.25%261M | -522.22%-76M | -39M | 34M | 156M | 144M | 18M |
| Income tax | -75.94%77M | 209.22%320M | 77.85%-66M | 144.44%8M | -7M | 385M | -293M | -298M | -18M |
| Net income | 116.31%23M | -131.33%-141M | -25.96%328M | -329.73%-85M | -32M | -351M | 450M | 443M | 37M |
| Net income continuous operations | 116.31%23M | -131.33%-141M | -25.96%328M | -329.73%-85M | ---32M | ---351M | --450M | --443M | --37M |
| Noncontrolling interests | -371.43%-19M | 7M | 1M | 2M | 0 | -2M | 0 | 0 | 0 |
| Net income attributable to the company | 128.19%42M | -133.11%-149M | -26.41%326M | -337.84%-88M | -33M | -354M | 450M | 443M | 37M |
| Preferred stock dividends | |||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 128.19%42M | -133.11%-149M | -26.41%326M | -337.84%-88M | -33M | -354M | 450M | 443M | 37M |
| Gross dividend payment | |||||||||
| Basic earnings per share | 126.17%5.85 | -130.10%-22.35 | -27.31%53.1 | -312.20%-13.05 | -5.55 | -58.35 | 74.25 | 73.05 | 6.15 |
| Diluted earnings per share | 126.17%5.85 | -130.10%-22.35 | -27.31%53.1 | -312.20%-13.05 | -5.55 | -58.35 | 74.25 | 73.05 | 6.15 |
| Dividend per share | |||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |